Funding for this research was provided by:
Academic Sinica Genomics Research Center Summit Project (AS-SUMMIT-108)
Article History
Received: 5 December 2019
Accepted: 23 January 2020
First Online: 14 February 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Patent applications of monoglycosylated influenza vaccines have been submitted by Academia Sinica with C.M., J.R.C. and Y.C.T. as inventors. RuenHuei Biopharmaceuticals, Inc. is in co-development with OPKO Health, Inc. on the monoglycosylated influenza vaccine technology licensed by Academia Sinica.